Search Within

Soo Ryum Yang

Formats
  1. Meeting Abstract (43)
  2. Journal Article (33)
  3. Review (8)
  4. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (85)
  2. Department of Medicine (69)
  3. Solid Tumor Oncology Division (69)
  4. Thoracic Oncology (66)
  5. GSK Faculty (59)
  6. Human Oncology and Pathogenesis Program (51)

More Groups

People
  1. Marc Ladanyi (47)
  2. Alexander Drilon (33)
  3. Jason Chang (33)
  4. Natasha Rekhtman (30)
  5. Michael Offin (26)
  6. William Travis (26)

More People

Years
  1. 2025 (16)
  2. 2024 (14)
  3. 2023 (19)
  4. 2022 (14)
  5. 2021 (16)
  6. 2020 (6)
Publications
  1. Laboratory Investigation (16)
  2. Journal of Thoracic Oncology (12)
  3. Journal of Clinical Oncology (11)
  4. Modern Pathology (8)
  5. Clinical Cancer Research (4)
  6. Journal of Molecular Diagnostics (4)

More Publications

Publishers
  1. Nature Publishing Group (22)
  2. American Society of Clinical Oncology (14)
  3. Elsevier Inc. (13)
  4. Nature Research (9)
  5. American Association for Cancer Research (7)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consensus guideline for the management of peritoneal mesothelioma
    Review

    Brown, L. M.; Wilkins, S. G.; Bansal, V. V.; Su, D. G.; Gomez-Mayorga, J.; Turaga, K. K.; Gunderson, C. G.; Lee, B.; Nash, G. M.; Hays, J. L.; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • The mutagenic forces shaping the genomes of lung cancer in never smokers
    Journal Article

    Díaz-Gay, M.; Zhang, T.; Hoang, P. H.; Leduc, C.; Baine, M. K.; Travis, W. D.; Sholl, L. M.; Joubert, P.; Khandekar, A.; Zhao, W.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • A phase II study of cabozantinib in patients with MET-altered lung cancers
    Journal Article

    Harada, G.; Santini, F. C.; Wilhelm, C. J.; Repetti, R. W.; Chang, J. C.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Goldstein, M.; more...
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Routine implementation of the Idylla Fusion assay: An assessment of performance based on prospective reflex testing of non-small cell lung carcinoma in a large laboratory setting
    Meeting Abstract

    Yakoub, M.; Pujadas, E.; Kim, D.; Yang, S. R.; Nafa, K.; Arcila, M.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Immunohistochemistry for the detection of STK11 (LKB1) genomic alterations in lung adenocarcinoma
    Meeting Abstract

    Saliba, M.; Febres-Aldana, C.; Baine, M.; Yang, S. R.; Sauter, J.; Travis, W.; Rudin, C.; Ladanyi, M.; Rekhtman, N.; Chang, J.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Integrated histological and molecular profiling of early-stage R0, resected non-mucinous lung adenocarcinomas
    Meeting Abstract

    Khan, I.; Aly, R. G.; Reiner, A.; Tan, K. S.; Rekhtman, N.; Chang, J.; Baine, M.; Chaft, J.; Travis, W.; Yang, S. R.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • MTAP loss by immunohistochemistry predicts worse survival and poor response to pemetrexed chemotherapy in pleural mesothelioma
    Meeting Abstract

    Saliba, M.; Arfe, A.; Baine, M.; Bodd, F.; Chang, J.; Ortiz, E.; Wilson, C.; Linkov, I.; Mayoral, M.; Offin, M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Impact of MTAP deletion on immunotherapy outcomes in patients with mesothelioma
    Meeting Abstract

    Ross, J.; Ortiz, E.; Barraza, G.; Mayoral, M.; Ginsberg, M. S.; Luongo, A.; Arfe, A.; Zauderer, M. G.; Adusumilli, P. S.; Eckert, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of oncogenic MET fusions reveals distinct pathogenomic subsets with differential sensitivity to MET-targeted therapy
    Journal Article

    Febres-Aldana, C. A.; Vojnic, M.; Odintsov, I.; Zhang, T.; Cheng, R.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A. M.; Gili, L.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • RRAS and RRAS2 hotspot mutations as novel actionable oncogenic drivers in lung adenocarcinoma
    Meeting Abstract

    Ladanyi, M.; Yang, S. R.; Zhang, T.; de Stanchina, E.; Somwar, R.
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save